Pfenex, Inc. has entered into a research collaboration with bioengineering solutions provider, DNA2.0, to develop an optimized algorithm and process for the design and synthesis of genes to be expressed in Pseudomonas fluorescens, the microorganism used in the Pfenex Expression Technology platform.   “Pfenex Inc. is dedicated to the rapid and reliable production of high quality recombinant proteins for our partners,” said Dr. Bertrand Liang, chief executive officer of Pfenex. “Through this colla...